Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of TQ05105 tablets in intermediate/high-risk myelofibrosis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• TQ05105

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Myelofibrosis | Phase 2 | Status: NOT_YET_RECRUITING